王鹏程 刘杰 李军 刘毕欧 刘玉银.不解剖GLISSON鞘区域血流阻断肝脏肿瘤切除[J].现代生物医学进展英文版,2014,14(33):6470-6472. |
不解剖GLISSON鞘区域血流阻断肝脏肿瘤切除 |
Clinical Application of“Without Anatomical Glisson Sheath”RegionalVascular Occlusion in Hepatectomy |
|
DOI: |
中文关键词: Glisson 鞘 肝血流阻断 肝切除术 |
英文关键词: Glisson sheath Hepatic vascular occlusion Hepatectomy |
基金项目:国家自然科学基金项目(30340058) |
|
Hits: 791 |
Download times: 837 |
中文摘要: |
目的:探讨不解剖Glisson 鞘区域血流阻断肝脏肿瘤切除的临床应用价值。方法:回顾性分析哈尔滨医科大学附属第一医院
普外科2000 年6 月-2013 年6 月对40 例肝脏肿瘤患者施行的肝部分切除术的临床资料。将手术分为不解剖Glisson 鞘区域血流
阻断切肝组(A组) 20 例和第一肝门入肝血流阻断切肝组(B组)20 例,比较两组术后的手术时间、术中出血量、术中输血量、术后
肝功能的恢复、术后并发症以及住院时间等情况。结果:两组在手术时间方面存在明显差异。而其他指标,如术中出血量、术中输
血量、术后肝功能的恢复、术后并发症以及住院时间等,A 组也明显优于B 组。结论:不解剖Glisson 鞘区域血流阻断技术能够有
效的控制术中出血,减轻肝脏缺血再灌注损伤,防止术中由门静脉介导的癌细胞肝内扩散,是一种合理的血流阻断方法。 |
英文摘要: |
Objective:To explore the value of clinical application of “without anatomical Glisson sheath”regional vascular
occlusion in hepatectomy.Methods:This is a retrospective study on the clinical data of 40 patients who underwent segmentectomy at the
General Surgery Department of First Affiliated Hospital of Harbin Medical University from 2000 to 2013. Among the 40 patients, 20
cases (Group A)were performed “without anatomical Glisson sheath”regional vascular occlusion, the rest (Group B) were performed
continuous hepatic vascular occlusion. The operative duration, the intraoperative blood loss, the blood transfusion, the postoperative
complications, the postoperative liver function recovery and the length of hospital stay were compared between two groups.Results:In
both groups, there was a significant difference in operative duration. The intraoperative blood loss, the blood transfusion, the
postoperative liver function recovery as well as the length of hospital stay in Group A were significantly superior to that in Group B.Conclusion:It is “without anatomical Glisson sheath”regional vascular occlusion that is an effective and feasible method that can
notably control the amount of blood loss, decrease the residual liver ischemia-reperfusion injury as well as prevent the spread of liver
cancer mediated by the portal vein. |
View Full Text
View/Add Comment Download reader |
Close |